Results 11 to 20 of about 12,698 (210)
Bromocriptine Use in Peripartum Cardiomyopathy: Review of Cases [PDF]
American Journal of Perinatology Reports, 2018 Objective This study is to review published cases of peripartum cardiomyopathy (PPCM) treated with bromocriptine and outline pros and cons of the treatment strategy.
Rebecca Simon +2 more
doaj +2 more sources
Repurposing of Bromocriptine for Cancer Therapy [PDF]
Frontiers in Pharmacology, 2018 Bromocriptine is an ergot alkaloid and dopamine D2 receptor agonist used to treat Parkinson’s disease, acromegaly, hyperprolactinemia, and galactorrhea, and more recently diabetes mellitus.
Ean-Jeong Seo +3 more
doaj +2 more sources
Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis [PDF]
Cancer Cell International, 2007 Background Prolactinoma is the most frequent pituitary tumor in humans. The dopamine D2 receptor agonist bromocriptine has been widely used clinically to treat human breast tumor and prolactinoma through inhibition of hyperprolactinemia and induction of ...
Huang Mu-Chiou +7 more
doaj +2 more sources
PLoS ONEBromocriptine, generally regarded as a dopamine D2 receptor agonist, has been used to treat patients with type 2 diabetes in the USA; however, its mechanisms of action including the receptors that mediate its anti-diabetic effects remain unclear ...
Hiroshi Tsuneki +11 more
doaj +2 more sources
Diabetes, Metabolic Syndrome and Obesity, 2010 Michael A Via1, Himani Chandra2, Takako Araki1, Matthew V Potenza3, Maria Skamagas41Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, NY, USA; 2Division of Endocrinology, Diabetes and ...
Via MA
doaj +2 more sources
Treatment of Acromegaly with Bromocriptine
Australian and New Zealand Journal of Medicine, 1979 Summary: Five men and three women with active acromegaly were treated with bromocriptine. After three months' therapy (30 mglday) mean GH during the day decreased by 50% in six out of eight subjects. In the remaining two subjects (non‐responders) GH was persistently over 100 μg/1.
Yeung, RTT, Wang, C, Chan, V
openaire +5 more sources
Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis
Frontiers in Endocrinology, 2023 ObjectiveBromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown.
Yiqun Tang +9 more
doaj +1 more source
Bromocriptine in Parkinsonism [PDF]
BMJ, 1974 Bromocriptine, a drug acting directly upon dopaminergic receptors, has been found to have a significant therapeutic action in a double-blind study of 20 patients with idiopathic Parkinsonism who were already receiving conventional therapy, including levodopa.
D B, Calne +5 more
openaire +2 more sources
THE EFFECT OF BROMOCRIPTINE ON C-REACTIVE PROTEIN IN WOMEN WITH HYPERPROLACTINEMIC AMENORRHEA [PDF]
The Medical Journal of Basrah University, 2008 C-reactive protein has become the subject of avid interest in recent years. Increased concentrations of C-reactive protein (CRP) became widely accepted as a risk factor of many inflammatory diseases including atherosclerosis, ischemic vascular diseases ...
Isam Hamo Mahmood
doaj +1 more source
Current Therapeutic Research, 2021 : Background: Although dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia, there is an identified relationship between the utilization of D2-like ...
Mohammed Fouad Shalaby, MD +5 more
doaj +1 more source